Yamamoto T, Johnson M A, Anderson J P. "Method for the Synthesis of Remimazolam Impurity 13" [P]. US Patent, US 9422118 B2, 2019-05-06.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 瑞马唑仑杂质13 in Pharmaceutical Formulations". Anal. Chem., 2015, 2218, (6), 353-366.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 瑞马唑仑杂质13 as an Impurity". Phytochemistry, 2010, 1937, 4370-4388.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Remimazolam Impurity 13 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2017, 1796, 3207-3234.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 瑞马唑仑杂质13 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2019, 945, (7), 5127-5136.